BIOTRONIK Excellence for Life

At BIOTRONIK, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology.

The Difference We Make

Highlights

  • Expert Insights on Conduction System Pacing

    Expert-led webinar replays exploring the latest clinical evidence, implantation techniques, and real-world experience with Conductive System Pacing.

    • Clinical insights from experienced electrophysiologists
    • Practical guidance on LBBAP and His Bundle pacing
    • Evidence, outcomes, and case-based discussions
    Get Full Access to Webinar Library
    Conduction System Pacing
  • Pulsed Field Ablation (PFA)

    Keep What Works. Add What's Next.

    Pulsed Field Ablation (PFA) is transforming the treatment of atrial fibrillation.

    With the Centauri™ PFA System, BIOTRONIK offers an approach designed to integrate PFA into today’s electrophysiology lab while building on established workflows, mapping systems and catheters.

    Supported by a growing body of clinical evidence, Centauri™ helps physicians take the next step in AF ablation.

    Discover Centauri™ PFA System
    Centauri
  • BRINGING DIGITAL INNOVATION FROM LAB TO LIFE IN CARDIOLOGY

    BIOTRONIK, Charité and German Heart Center Foundation Partner to Advance Digital Cardiology

    BIOTRONIK, Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation have launched a first-of-its-kind research and innovation partnership to accelerate digital and translational cardiology. 

    The collaboration combines clinical expertise, AI, connected health technologies, and cardiac device innovation to bring new digital solutions from research into patient care. Initial projects will focus on AI-driven tools, advanced simulation environments, and the next generation of cardiovascular specialists. 

    FIND OUT MORE
  • WORLD HEART DAY

    Don't Miss a Beat. Every Heartbeat Has a Story.

    This World Heart Day, BIOTRONIK is shining a light on the people behind the diagnosis. Through authentic patient stories, we explore the journey from recognizing symptoms and seeking answers to treatment, recovery, and living confidently with a heart condition. 

    Join us in raising awareness and helping more people take charge of their heart health.

    Discover their stories
    World Heart Day Camapaign 2026

  • Prospera™ Spinal Cord Stimulation System with Embrace One™

    BIOTRONIK Neuro’s Prospera spinal cord stimulation (SCS) system treats patients suffering from chronic pain, helping them embrace life again. The system uniquely features:

    • RESONANCE™, the first and only multiphase stimulation paradigm
    • Embrace One, a truly first-of-its-kind ecosystem that provides automatic, objective, remote daily monitoring

    Prospera SCS System is approved in the US only and is not available outside of the US.

    Note: Embrace One is a support platform intended to help manage a patient’s experience with spinal cord stimulation. It is not intended to be used for medical diagnosis or medical treatment.

    Find out more
    Prospera™ Spinal Cord Stimulation System

    Press Releases

    Visit our Newsroom
    BIOTRONIK Acticor Sky HF-T
    LAKE OSWEGO, Oregon, USA

    BIOTRONIK Announces First U.S. Implant of Acticor Sky CRT-DX

    BIOTRONIK, a global leader in cardiovascular medical technology, today announced the first U.S. implant of its Acticor Sky DX cardiac resynchronization therapy defibrillator (CRT-D) system. This marks an important milestone following recent U.S. Food and Drug Administration (FDA) approval of its broader Acticor Sky and Rivacor Sky device family. The procedure was successfully performed by Niraj Varma, MD, PhD, Electrophysiologist at Cleveland Clinic, and represents the first clinical use of Acticor Sky CRT-DX in the United States. “In performing the first U.S. implant of this device, what
    MUNICH, Germany

    New Evidence for ICD Decision-Making in Cardiomyopathy Patients with LVEF 36-50% Presented at ESC Congress

    BIOTRONIK-Supported CMR-GUIDE Trial Evaluates Scar-Based Risk Stratification for ICD Therapy Primary Endpoint Neutral; Secondary Endpoint Shows Reduced Sudden Cardiac Death with ICD Therapy Results from the CMR-GUIDE study were presented by Principal Investigator Prof Dr. Joseph Selvanayagam, Chair of Cardiovascular Medicine at Flinders University, Flinders Medical Centre, Adelaide, Australia, during a Hotline Session at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. The findings were also published online in JAMA. Current guidelines generally do not recommend
    Prospera
    MIAMI, Florida, USA
    Press Release

    BIOTRONIK Neuro Launches Embrace One® Proactive Intelligence, a Proprietary AI Capability that Identifies Emerging Support Needs in SCS Patients

    BIOTRONIK Neuro today announced the launch of Embrace One ® Proactive Intelligence, a proprietary AI capability that advances proactive care for patients implanted with the Prospera ® Spinal Cord Stimulation (SCS) System. BIOTRONIK Neuro collects more than 200 data points per patient daily through automatic, objective remote monitoring, and the new AI capability analyzes this data to identify early signals that may indicate a patient could benefit from additional support or therapy optimization. The AI model does not make clinical decisions or adjust therapy. Instead, it provides additional

    We Take Our Responsibility Seriously

    Advancing Health and Well-Being Since 1963

    BIOTRONIK is proud of its 60-year history of life-changing innovations and service to the healthcare community. ​

    The development of the first German pacemaker in 1963 laid the foundation for who we are today. Read more about our journey from pioneer to global leader.

    Explore Our History
    Devices from old to new

    Making a Difference with Heart

    Corporate responsibility is an integral part of who we are and how we do business. We understand that our success is also measured by the positive impact we have on society, the environment, and the well-being of patients and our employees. ​

    This is why we are committed to continually improving and setting higher standards in these crucial areas. 

    Discover Our Commitment to Responsibility
    Young employees talk to each other